Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6423699

Combination therapies using benzimidazolones

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6417214

3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6417212

Modulators of peroxisome proliferator activated receptors

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6413952

Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating meta

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6413740

Tyrosine kinase receptors and ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6407101

Cyanopyrroles

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6407132

Substituted imidazole derivatives and their use as histamine H3 receptor ligands

The James Black Foundation Limited · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6399593

Cyclic regimens using cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6395882

Selectin ligands

The Regents of the University of California · Granted Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6391907

Indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6380371

Endoglycan: a novel protein having selectin ligand and chemokine presentation activity

The Regents of the University of California · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6380235

Benzimidazolones and analogues

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6380207

Glucocortiocoid-selective antiinflammatory agents

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6369056

Cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6358948

Quinazolinone and benzoxazine derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6358947

Tetracyclic progesterone receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6355648

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6352694

Methods for inducing a population of T cells to proliferate using agents which recognize T

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6339098

2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6325999

Use of Fas ligand to suppress T-lymphocyte-mediated immune responses

The Regents of the University of Technology Office of Technology Transfer · Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6319912

Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6320074

Compounds having selective activity for retinoid X receptors, and means for modulation of

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired